123 related articles for article (PubMed ID: 16414249)
21. Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Haro JM; Novick D; Suarez D; Alonso J; Lépine JP; Ratcliffe M;
J Clin Psychopharmacol; 2006 Dec; 26(6):571-8. PubMed ID: 17110813
[TBL] [Abstract][Full Text] [Related]
22. Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
Novick D; Ascher-Svanum H; Brugnoli R; Bertsch J; Hong J; Haro JM
J Nerv Ment Dis; 2012 Jul; 200(7):637-43. PubMed ID: 22759944
[TBL] [Abstract][Full Text] [Related]
23. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Dossenbach M; Arango-Dávila C; Silva Ibarra H; Landa E; Aguilar J; Caro O; Leadbetter J; Assunção S
J Clin Psychiatry; 2005 Aug; 66(8):1021-30. PubMed ID: 16086618
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Gasquet I; Haro JM; Novick D; Edgell ET; Kennedy L; Lepine JP;
Int Clin Psychopharmacol; 2005 Jul; 20(4):199-205. PubMed ID: 15933480
[TBL] [Abstract][Full Text] [Related]
25. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
[TBL] [Abstract][Full Text] [Related]
26. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
[TBL] [Abstract][Full Text] [Related]
27. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
Landolt K; Rössler W; Ajdacic-Gross V; Derks EM; Libiger J; Kahn RS; Fleischhacker WW;
Schizophr Res; 2016 Apr; 172(1-3):145-51. PubMed ID: 26922655
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO).
Bitter I; Czobor P; Dossenbach M; Volavka J
Eur Psychiatry; 2005 Aug; 20(5-6):403-8. PubMed ID: 16084068
[TBL] [Abstract][Full Text] [Related]
29. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
[TBL] [Abstract][Full Text] [Related]
30. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.
Usall J; Suarez D; Haro JM;
Psychiatry Res; 2007 Dec; 153(3):225-31. PubMed ID: 17681611
[TBL] [Abstract][Full Text] [Related]
31. [The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics].
Gasquet I; Chartier F; Tcherny-Lessenot S; Lépine JP
Rev Epidemiol Sante Publique; 2009 Feb; 57(1):25-32. PubMed ID: 19162420
[TBL] [Abstract][Full Text] [Related]
32. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.
Ascher-Svanum H; Zhu B; Faries D; Lacro JP; Dolder CR
J Clin Psychiatry; 2006 Jul; 67(7):1114-23. PubMed ID: 16889456
[TBL] [Abstract][Full Text] [Related]
33. The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment.
Haro JM; Edgell ET; Frewer P; Alonso J; Jones PB;
Acta Psychiatr Scand Suppl; 2003; (416):7-15. PubMed ID: 12755849
[TBL] [Abstract][Full Text] [Related]
34. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
Novick D; Haro JM; Bertsch J; Haddad PM
J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
[TBL] [Abstract][Full Text] [Related]
35. Health-related quality of life (HRQL) and continuous antipsychotic treatment: 3-year results from the Schizophrenia Health Outcomes (SOHO) study.
Alonso J; Croudace T; Brown J; Gasquet I; Knapp MR; Suárez D; Novick D
Value Health; 2009 Jun; 12(4):536-43. PubMed ID: 19900255
[TBL] [Abstract][Full Text] [Related]
36. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia.
Edlinger M; Hofer A; Rettenbacher MA; Baumgartner S; Widschwendter CG; Kemmler G; Neco NA; Fleischhacker WW
Schizophr Res; 2009 Sep; 113(2-3):246-51. PubMed ID: 19595578
[TBL] [Abstract][Full Text] [Related]
38. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
Kerwin R; Millet B; Herman E; Banki CM; Lublin H; Pans M; Hanssens L; L'Italien G; McQuade RD; Beuzen JN
Eur Psychiatry; 2007 Oct; 22(7):433-43. PubMed ID: 17555947
[TBL] [Abstract][Full Text] [Related]
39. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study.
Novick D; Haro JM; Suarez D; Marques-Teixeira J; Naber D
Int Clin Psychopharmacol; 2008 Jul; 23(4):203-8. PubMed ID: 18545058
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
Bitter I; Treuer T; Dyachkova Y; Martenyi F; McBride M; Ungvari GS
Eur Neuropsychopharmacol; 2008 Mar; 18(3):170-80. PubMed ID: 17884390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
